A Changed Landscape? The Impact of the Myriad Decision on Dx Companies

Personalized Medicine World Conference 2014

01/27/2014 - 01/28/2014

Life Sciences, Patent Litigation, and Intellectual Property Litigation

Computer History Museum
1401 N Shoreline Blvd
Mountain View, CA 94043

Catherine M. Polizzi

Catherine M. Polizzi

Speaking Engagement

Catherine Polizzi will be on a panel that will discuss the impact of the Supreme Court’s 2013 Myriad decision on multiple aspects of the personalized medicine diagnostics industry.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.